MARATTO

review · Ocular Immunology and Inflammation

Efficacy and Safety of Lotilaner Ophthalmic Solution 0.25% in the Treatment of Demodex Blepharitis: A Systematic Review and Meta-Analysis

20245 citationsOpen accessKafr el-Sheikh University

Abstract

Our findings show that lotilaner might effectively treat Demodex blepharitis. However, further RCTs with larger and more diverse populations are needed to confirm these findings as some outcomes show significant heterogeneity.

Research topics

  • Acne and Rosacea Treatments and Effects
  • Healthcare and Venom Research
  • Contact Dermatitis and Allergies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/09273948.2024.2309552

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.